Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC5A2 | P31639 | 8/20 | 0.61 |
| ▸ | SLC5A1 | P13866 | 6/20 | 0.61 |
| ▸ | NPC1 | O15118 | 1/20 | 0.60 |
| ▸ | RAB9A | P51151 | 1/20 | 0.60 |
| ▸ | TYR | P14679 | 1/20 | 0.56 |
| ▸ | ACHE | P22303 | 1/20 | 0.54 |
| ▸ | CD209 | Q9NNX6 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5787376 | 1.00 | SLC5A2 (0.61) | SLC5A2SLC5A1NPC1RAB9ATYR | |
| SCHEMBL9001307 | 1.00 | SLC5A2 (0.61) | SLC5A2SLC5A1NPC1RAB9ATYR | |
| SCHEMBL11940290 | 1.00 | SLC5A2 (0.61) | SLC5A2SLC5A1NPC1RAB9ATYR | |
| SCHEMBL11891009 | 1.00 | SLC5A2 (0.61) | SLC5A2SLC5A1NPC1RAB9ATYR | |
| SCHEMBL23266197 | 1.00 | SLC5A2 (0.61) | SLC5A2SLC5A1NPC1RAB9ATYR | |
| SCHEMBL15925919 | 1.00 | SLC5A2 (0.61) | SLC5A2SLC5A1NPC1RAB9ATYR | |
| SCHEMBL23266259 | 1.00 | SLC5A2 (0.61) | SLC5A2SLC5A1NPC1RAB9ATYR | |
| SCHEMBL5787383 | 1.00 | SLC5A2 (0.61) | SLC5A2SLC5A1NPC1RAB9ATYR | |
| SCHEMBL11026136 | 1.00 | SLC5A2 (0.61) | SLC5A2SLC5A1NPC1RAB9ATYR | |
| SCHEMBL6225078 | 0.99 | SLC5A2 (0.59) | SLC5A2SLC5A1NPC1RAB9ATYR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140370501-A1 | HYDROLASE ENZYME SUBSTRATES AND USES THEREOF | DIAZYME LABORATORIES, INC. | 2014-12-18 | — | — | US | disclosed |
| US-20140329241-A1 | HYDROLASE ENZYME SUBSTRATES AND USES THEREOF | DIAZYME LABORATORIES, INC. | 2014-11-06 | — | — | US | disclosed |
| US-8795979-B2 | Hydrolase enzyme substrates and uses thereof | GENERAL ATOMICS (US) | 2014-08-05 | — | — | US | disclosed |
| US-20120190013-A1 | HYDROLASE ENZYME SUBSTRATES AND USES THEREOF | DIAZYME LABORATORIES, INC. | 2012-07-26 | — | — | US | disclosed |
| US-6235720-B1 | DRUG; MICROBIOCIDE, VIRICIDE, BACTERICIDE, ANTIPROTOZOA AGENT | GELTEX PHARMACEUTICALS, INC. | 2001-05-22 | — | — | US | disclosed |
| US-5939537-A | Acid-functionalized saccharide monomers | GELTEX PHARMACEUTICALS INC. (US) | 1999-08-17 | — | — | US | disclosed |
| EP-0929562-A1 | ACID-FUNCTIONALIZED SACCHARIDES AS POLYVALENT ANTI-INFECTIVES | GELTEX PHARMACEUTICALS, INC. (US) | 1999-07-21 | — | — | EP | disclosed |
| US-5821312-A | Acid-functionalized saccharides as polyvalent anti-infectives | GELTEX PHARMACEUTICALS, INC. (US) | 1998-10-13 | — | — | US | disclosed |
| WO-1998012203-A1 | ACID-FUNCTIONALIZED SACCHARIDES AS POLYVALENT ANTI-INFECTIVES | GELTEX PHARMACEUTICALS, INC. (US) | 1998-03-26 | — | — | WO | disclosed |
| US-5700458-A | Acid-functionalized saccharides as polyvalent anti-infectives | GELTEX PHARMACEUTICALS INC. (US) | 1997-12-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120190013-A1 | HYDROLASE ENZYME SUBSTRATES AND USES THEREOF | DNPH1, HDHD5, ENGASE | SLC5A2 4741/4885SLC5A1 4571/4885NPC1 2008/4885 |
| US-20140370501-A1 | HYDROLASE ENZYME SUBSTRATES AND USES THEREOF | DNPH1, HDHD5, ENGASE | SLC5A2 4741/4885SLC5A1 4571/4885NPC1 2008/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.